This will be over soon. We know from FOIAs the SEC was watching them. We now know the FDA hates their guts. The SEC hasn't granted them an effective S-3. It will be interesting to see what happens if Fife stops funding CYDY. If that happens its game over because they have scrapped the bottom of the barrel in terms of funding with Fife and the ineffective S-3 precludes them from raising primary capital (on which Fife would have a ROFR too)
News 
Market Data 
Discover 
